IL‐17A gene signatures based on IL‐17A stimulation in various cell types (keratinocytes, fibroblasts, whole skin) showed an increase in median expression levels in HS lesional skin compared with healthy or HS non‐lesional skin, suggesting IL‐17A pathway engagement in HS (Figure 1B). Here, IL17A is linked to histiocytic sarcoma.